Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2000255 | Molecular Genetics and Metabolism | 2007 | 4 Pages |
Abstract
We report a recessive mutation in the tyrosine hydroxylase gene (TH) promoter (c.1−71C>T), present at homozygosity in a patient with dopa-responsive encephalopathy. The change lies in a cAMP response element (CRE) and alters a binding site for the CREM transcription factor. Previous studies support that the CRE in the TH gene is essential for its transcription, suggesting that mutations within this consensus motif may cause an impairment of catecholamine biosynthesis and lead to a pathogenic phenotype.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Marta Ribasés, Mercedes Serrano, Emilio Fernández-Álvarez, Sandra Pahisa, Aida Ormazabal, Àngels García-Cazorla, Belén Pérez-Dueñas, Jaume Campistol, Rafael Artuch, Bru Cormand,